Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adipose Tissue
33%
Between-person
33%
Cardiometabolic Disease
16%
CD14+ Monocytes
16%
Clinical Trial Registry
16%
Cytokine Response
16%
Differential Expression
100%
Differentially Expressed
66%
Differentially Expressed Genes
16%
Endotoxemia
100%
Endotoxin Challenge
16%
Evoked Response
16%
Extreme Response
100%
Gene number
33%
Genome-wide Association Study
16%
Healthy Individuals
16%
High Responder
50%
Human-specific
16%
Inflammation
16%
Inflammatory Diseases
16%
Inflammatory Response
33%
Innate Immune Response
16%
Innate Immunity Activation
16%
Interleukin-6
16%
Interleukin-6 Expression
16%
Knockdown
16%
Lipopolysaccharide
66%
Lipopolysaccharide-induced
33%
Long Intergenic Non-coding RNA
100%
Long Non-coding RNA (LncRNA)
100%
Low Responder
33%
Metabolic Response
16%
Monocytes
50%
N-15
16%
Niacin
16%
Novel Genes
100%
RNA Regulator
16%
RNA Sequencing (RNA-seq)
16%
THP-1 Cells
16%
Tissue Response
16%
Tissue-specific Transcriptome
16%
Transcriptional Response
16%
Unique Identifier
16%
Biochemistry, Genetics and Molecular Biology
CD14
16%
Clinical Trial
16%
Cytokine Response
16%
Differentially Expressed Gene
33%
Evoked Potential
16%
Genetics
16%
Genome-Wide Association Study
16%
Genomics
16%
Innate Immunity
33%
Interleukin 6
33%
Lipopolysaccharide
100%
Long Non-Coding RNA
100%
Messenger RNA
16%
Metabolic Pathway
16%
Monocyte
83%
Niacin
16%
Non-Coding RNA
100%
Normal Human
16%
RNA Sequence
16%
Tissue Reaction
16%
Transcriptomics
16%
Immunology and Microbiology
Adipose Tissue
40%
CD14
20%
Cytokine Response
20%
Evoked Response
20%
Genome-Wide Association Study
20%
Inflammation
20%
Inflammation Response
40%
Innate Immune System
40%
Interleukin 6
40%
Monocyte
100%
Normal Human
20%
Ribonucleic Acid
100%
RNA Sequence
20%
Tissue Reaction
20%
Transcriptomics
20%